首页> 美国卫生研究院文献>The British Journal of Cancer. Supplement >Immunohistochemical identification of CA125 and the F(ab)2 fragments of the murine monoclonal antibody OC125 in ovarian cancer tissue.
【2h】

Immunohistochemical identification of CA125 and the F(ab)2 fragments of the murine monoclonal antibody OC125 in ovarian cancer tissue.

机译:卵巢癌组织中CA125和鼠单克隆抗体OC125的F(ab)2片段的免疫组织化学鉴定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Benign and malignant tissue samples of 19 ovarian cancer patients who received an intravenous infusion of radiolabelled F(ab')2 fragments of OC125 were examined for expression of CA125 and the cellular location of the injected antibodies. CA125 could be detected by immunohistochemistry in 47 of 71 biopsies containing cancer cells, but not in 258 biopsies with benign tissue. F(ab')2 fragments were found in 34 of these 47 biopsies. The diffuse intracytoplasmic staining pattern seemed to indicate that the injected antibodies had crossed the membranes of the cancer cells. Since the antibody could not be detected in benign tissues, further applications of OC125 for diagnostic and therapeutic purposes seems to be justified.
机译:检查了19名卵巢癌患者的良性和恶性组织样品,这些患者接受了OC125放射性标记的F(ab')2片段的静脉内输注,以检测CA125的表达和注射抗体的细胞位置。 CA125可以通过免疫组织化学在71份含有癌细胞的活检组织中检测到,而在258份具有良性组织的活检组织中检测不到。在这47次活检中有34次发现F(ab')2片段。弥漫性胞浆内染色模式似乎表明注射的抗体已经穿过癌细胞的膜。由于在良性组织中无法检测到抗体,因此将OC125进一步用于诊断和治疗目的似乎是合理的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号